PeptiDream Inc. (TYO: 4587)
Japan
· Delayed Price · Currency is JPY 2,184.00
+71.00 (3.36%)
Jan 20, 2025, 3:30 PM JST
PeptiDream Revenue
PeptiDream had revenue of 5.47B JPY in the quarter ending September 30, 2024, a decrease of -58.29%. This brings the company's revenue in the last twelve months to 47.77B, up 25.10% year-over-year. In the year 2023, PeptiDream had annual revenue of 28.71B with 6.93% growth.
Revenue (ttm)
47.77B
Revenue Growth
+25.10%
P/S Ratio
5.93
Revenue / Employee
65.00M
Employees
603
Market Cap
283.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 28.71B | 1.86B | 6.93% |
| Dec 31, 2022 | 26.85B | 17.49B | 186.70% |
| Dec 31, 2021 | 9.37B | -2.31B | -19.79% |
| Dec 31, 2020 | 11.68B | 9.60B | 462.85% |
| Dec 31, 2019 | 2.07B | -5.14B | -71.25% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,142.35B |
| Daiichi Sankyo Company | 1,758.07B |
| HOYA Corporation | 812.74B |
| Takeda Pharmaceutical Company | 4,546.08B |
| Terumo | 986.67B |
| Otsuka Holdings | 2,269.56B |
| Astellas Pharma | 1,772.16B |
| Olympus | 973.60B |